Search Results

There are 8197 results for: content related to: Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study

  1. A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with Type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin

    Diabetic Medicine

    Volume 29, Issue 11, November 2012, Pages: e417–e424, R. Violante, J. H. A. Oliveira, K.-H. Yoon, V. A. Reed, M. B. Yu, O. P. Bachmann, J. Lüdemann and J. Y. C. Chan

    Article first published online : 7 OCT 2012, DOI: 10.1111/j.1464-5491.2012.03624.x

  2. Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes

    Diabetic Medicine

    Volume 29, Issue 12, December 2012, Pages: 1515–1523, G. Derosa, I. G. Franzetti, F. Querci, A. Carbone, L. Ciccarelli, M. N. Piccinni, E. Fogari and P. Maffioli

    Article first published online : 14 NOV 2012, DOI: 10.1111/j.1464-5491.2012.03699.x

  3. Acute tubulointerstitial nephritis following treatment with exenatide

    Diabetic Medicine

    Volume 30, Issue 1, January 2013, Pages: 123–125, H. Nandakoban, T. J. Furlong and J. R. Flack

    Article first published online : 13 DEC 2012, DOI: 10.1111/j.1464-5491.2012.03738.x

  4. Glucagon-like peptide analogues for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Deepson S. Shyangdan, Pamela Royle, Christine Clar, Pawana Sharma, Norman Waugh and Ailsa Snaith

    Published Online : 5 OCT 2011, DOI: 10.1002/14651858.CD006423.pub2

  5. Exenatide efficacy and safety: a systematic review

    Diabetic Medicine

    Volume 26, Issue 9, September 2009, Pages: 837–846, S. L. Norris, N. Lee, S. Thakurta and B. K. S. Chan

    Article first published online : 27 JUN 2009, DOI: 10.1111/j.1464-5491.2009.02790.x

  6. Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 6, June 2012, Pages: 546–554, M. S. Fineman, K. F. Mace, M. Diamant, T. Darsow, B. B. Cirincione, T. K. Booker Porter, L. A. Kinninger and M. E. Trautmann

    Article first published online : 10 FEB 2012, DOI: 10.1111/j.1463-1326.2012.01561.x

  7. Response to Nandakoban et al. Acute tubulointerstitial nephritis following treatment with exenatide

    Diabetic Medicine

    Volume 30, Issue 2, February 2013, Pages: 251–252, D. O. Rees, D. E. Price, S. C. Bain and J. W. Stephens

    Article first published online : 21 JAN 2013, DOI: 10.1111/dme.12014

  8. You have free access to this content
    Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 510–524, S. Cornell

    Article first published online : 21 MAR 2012, DOI: 10.1111/j.1365-2710.2012.01342.x

  9. You have full text access to this Open Access content
    Improved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks

    Journal of Diabetes Investigation

    Volume 2, Issue 3, June 2011, Pages: 210–217, Takashi Kadowaki, Mitsuyoshi Namba, Takeshi Imaoka, Ayuko Yamamura, Wakana Goto, Marilyn K. Boardman and Hideaki Sowa

    Article first published online : 10 DEC 2010, DOI: 10.1111/j.2040-1124.2010.00084.x

  10. Once weekly exenatide: efficacy, tolerability and place in therapy

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 10, October 2013, Pages: 871–881, C. Wysham, M. Grimm and S. Chen

    Article first published online : 24 MAR 2013, DOI: 10.1111/dom.12084

  11. An overview of once-weekly glucagon-like peptide-1 receptor agonists—available efficacy and safety data and perspectives for the future

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 5, May 2011, Pages: 394–407, S. Madsbad, U. Kielgast, M. Asmar, C. F. Deacon, S. S. Torekov and J. J. Holst

    Article first published online : 24 MAR 2011, DOI: 10.1111/j.1463-1326.2011.01357.x

  12. You have full text access to this Open Access content
    Long-term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes

    Journal of Diabetes Investigation

    Volume 2, Issue 6, December 2011, Pages: 448–456, Nobuya Inagaki, Kohjiro Ueki, Ayuko Yamamura, Hitoshi Saito and Takeshi Imaoka

    Article first published online : 26 JUN 2011, DOI: 10.1111/j.2040-1124.2011.00137.x

  13. You have full text access to this OnlineOpen article
    Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 6, June 2013, Pages: 485–502, R. Balena, I. E. Hensley, S. Miller and A. H. Barnett

    Article first published online : 12 NOV 2012, DOI: 10.1111/dom.12025

  14. You have free access to this content
    The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 8, August 2014, Pages: 673–688, J. Seufert and B. Gallwitz

    Article first published online : 16 JAN 2014, DOI: 10.1111/dom.12251

  15. You have full text access to this OnlineOpen article
    DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide

    Diabetic Medicine

    Volume 28, Issue 6, June 2011, Pages: 705–714, C. Wysham, R. Bergenstal, J. Malloy, P. Yan, B. Walsh, J. Malone and K. Taylor

    Article first published online : 16 MAY 2011, DOI: 10.1111/j.1464-5491.2011.03301.x

  16. You have free access to this content
    Exenatide: a review from pharmacology to clinical practice

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 6, June 2009, Pages: 544–556, R. Gentilella, C. Bianchi, A. Rossi and C. M. Rotella

    Article first published online : 5 APR 2009, DOI: 10.1111/j.1463-1326.2008.01018.x

  17. Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 8, August 2011, Pages: 703–710, K. Y. Thong, B. Jose, N. Sukumar, M. L. Cull, A. P. Mills, T. Sathyapalan, W. Shafiq, A. S. Rigby, C. Walton, R. E. J. Ryder and on behalf of the ABCD nationwide exenatide audit contributors

    Article first published online : 21 JUN 2011, DOI: 10.1111/j.1463-1326.2011.01393.x

  18. Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus

    The Journal of Clinical Pharmacology

    Volume 48, Issue 12, December 2008, Pages: 1389–1399, Dr Prajakti A. Kothare, Dr Helle Linnebjerg, Dr Yoshitaka Isaka, Mr Kazunori Uenaka, Dr Ayuko Yamamura, Dr Kwee Poo Yeo, Dr Amparo de la Peña, Dr Choo Hua Teng, Dr Kenneth Mace, Mr Mark Fineman, Dr Hirofumi Shigeta, Dr Yukikuni Sakata and Dr Shin Irie

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008323750

  19. Application of model-based methods to characterize exenatide-loaded double-walled microspheres: In vivo release, pharmacokinetic/pharmacodynamic model, and in vitro and in vivo correlation

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 10, October 2012, Pages: 3946–3961, Xingang Li, Liang Li, Xipei Wang, Yupeng Ren, Tianyan Zhou and Wei Lu

    Article first published online : 29 JUN 2012, DOI: 10.1002/jps.23236

  20. You have free access to this content
    Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity

    British Journal of Pharmacology

    Volume 163, Issue 2, May 2011, Pages: 399–412, Nian Gong, Ai-Niu Ma, Li-Jie Zhang, Xiao-Su Luo, Yin-Hui Zhang, Michael Xu and Yong-Xiang Wang

    Article first published online : 18 APR 2011, DOI: 10.1111/j.1476-5381.2011.01227.x